Short answer
Apogee Therapeutics, Inc. (APGE) filed an 8-K current report with the SEC on May 11, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Apogee announced financial results for quarter ended March 31, 2026.
Apogee Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Apogee announced financial results for quarter ended March 31, 2026
- Business update and detailed results furnished in Exhibit 99.1
- Investor focus: quarterly performance and pipeline developments disclosed in the earnings release
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Apogee Therapeutics, Inc. 8-K filings
Get the next APGE 8-K as it lands
Follow APGE for push alerts, or ask the research agent what this filing means.